default author photo

Wei-Hsuan Tang

Medigen Vaccine Biologics Corp.

SCHOLARLY PAPERS

1

DOWNLOADS

106

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase I, Prospective, Randomized, Open-Labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults

Number of pages: 26 Posted: 09 Sep 2022
Chia En Lien, Ming-Che Liu, Ning-Chi Wang, Luke Tzu Chi Liu, Chung-Chin Wu, Wei-Hsuan Tang, Wei-Cheng Lian, Kuan-Ying A. Huang and Charles Chen
Medigen Vaccine Biologics Corp., Taipei Medical University - Clinical Research Centre, National Defense Medical Center - Tri-Service General Hospital, Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Medigen Vaccine Biologics Corp., Chang Gung University - Research Center for Emerging Viral Infections and Medigen Vaccine Biologics Corp.
Downloads 106 (664,543)

Abstract:

Loading...

COVID-19, SARS-CoV-2, SARS-CoV-2 vaccine, MVC-COV1901, booster vaccination, SARS-CoV-2 Beta variant booster vaccine, Omicron variant